Global eating-disorder recovery nutrition market projected to grow from USD 242.2 million in 2026 to USD 639.8 million by 2036 at a 10.2% CAGR, according to Future Market Insights
The global Eating-Disorder Recovery Nutrition Market is projected to reach USD 639.8 million by 2036, up from USD 242.2 million in 2026, expanding at a 10.2% CAGR during the forecast period, according to the latest analysis by Future Market Insights (FMI).
The commercial base expands as more patients enter structured treatment and receive clinician-defined nutrition plans. Growth is further supported by rising clinical assessments for oral nutritional supplements (ONS), increasing adoption of compact high-calorie formats, and greater emphasis on care-setting continuity from hospital stabilization to community-based recovery.
Eating-disorder recovery nutrition comprises specialized oral and adjacent medical-nutrition products such as complete balanced oral nutritional supplements, structured refeeding products, compact high-calorie ONS, and refeeding-safe micronutrient repletion formulas. These products support supervised nutritional rehabilitation when ordinary food intake cannot fulfill prescribed energy goals.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-35065
Complete Balanced ONS Holds Largest Product Share Complete balanced ONS is expected to account for 38.9% of the product type segment in 2026, maintaining its position as the leading category.
Its primary share stems from broad nutrient coverage delivered in a single, repeatable format. This simplifies multi-disciplinary clinical care by providing predictable energy and protein without requiring treatment teams to assemble multiple separate nutritional items.
Category-defining products and reformulations continue to shape prescribing practices. Innovations such as compact high-calorie options and plant-based formulations are expanding choices to address refeeding risks, taste fatigue, and patient volume tolerance.
Inpatient and Residential Care Leads Care Settings The inpatient and residential care segment is projected to lead the care setting category, capturing 39.7% of demand in 2026.
High supervision intensity, rapid adjustments of prescribed intake, and close monitoring of electrolytes and fluid balance support institutional procurement in acute settings. However, the market is progressively extending toward PHP/IOP and outpatient/home-supported recovery settings as healthcare frameworks aim to maintain long-term step-down continuity.
Anorexia Nervosa Represents Core Diagnosis Application Anorexia nervosa is set to dominate the diagnosis category with a 46.9% share in 2026, driven by sustained weight restoration as a central therapeutic objective.
Prolonged restrictive eating makes medical stabilization and structured refeeding critical. Bulimia & binge-purge presentations, alongside OSFED (Other Specified Feeding or Eating Disorders), represent additional major clinical segments driving targeted nutritional support.
Hospital Pharmacies Anchor Sales Channels Hospital pharmacy is forecast to represent 36.6% of sales channel demand in 2026, reinforced by clinician-led selection and formulary control over high-acuity nutrition.
At the same time, maintaining patient supply continuity across retail pharmacies and home delivery channels remains essential. Uninterrupted access following hospital discharge prevents therapeutic disruption during step-down recovery phases.
South Korea and UK Lead Regional Growth Pace FMI’s country-level analysis highlights South Korea as the fastest-growing market among profiled nations, with a projected 10.4% CAGR through 2036, followed by the United Kingdom at 10.0%.
The United States is projected to grow at a 9.7% CAGR, Germany at 9.3%, and Japan at 8.2% during the forecast period.
Growth in South Korea is driven by strong professional guidance and hospital-led nutrition documentation. The UK market growth is underpinned by commissioned NHS eating-disorder pathways, while USA expansion is tied to a large specialist-treatment base, despite fragmentation across private and public payer models.
Competitive Landscape
The Eating-Disorder Recovery Nutrition Market features global medical-nutrition platforms alongside specialized oral nutrition companies.
Key companies profiled by FMI include Abbott Laboratories, Danone S.A. (Nutricia), Nestlé Health Science, Fresenius Kabi, Kate Farms, Ajinomoto Co., Inc. (Nualtra), Meiji Co., Ltd., and AYMES Nutrition.
Competitive positioning centers on finished ONS portfolio breadth, compact energy delivery, supply continuity post-intensive care, clinical trial support, and formulary access.
Analyst Perspective
“Recovery-nutrition products should be judged on how reliably they deliver a prescribed energy and nutrient plan without adding volume or switching friction. Commercial value is earned when the same approved format can follow a patient from intensive treatment into community and home recovery.”— Nandini Roy Choudhury, Principal Consultant, Future Market Insights
Exclusive Discounts on Full Report: https://www.futuremarketinsights.com/reports/eating-disorder-recovery-nutrition-market
Report Scope
The FMI study covers the Eating-Disorder Recovery Nutrition Market by product type, care setting, diagnosis, end user, sales channel, and region.
Product categories include complete balanced ONS, structured refeeding products, compact high-calorie ONS, micronutrient repletion products, and others. Care settings cover inpatient & residential, PHP/IOP programs, and outpatient & home recovery.
The research spans North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa, with the forecast period extending from 2026 to 2036.
FMI’s methodology combines primary interviews across manufacturers, healthcare providers, procurement teams, and subject-matter experts with secondary research, corporate filings, and statistical triangulation.
Key Executive Benefits
- Decision-Ready Insights
- Reduced Strategic Risk
- Market Entry Confidence
- Competitive Advantage
- Faster Growth Decisions
- Primary Market Validation
To explore how FMI Custom Research can support your strategic priorities, connect with our team at – [email protected]
About Future Market Insights (FMI)
Future Market Insights, Inc. is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization trusted by Fortune 500 companies. With a global presence across the U.S., UK, India, and Dubai, FMI delivers data-driven insights across 30+ industries and 1200 markets worldwide.
